.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 4,889,919

« Back to Dashboard

Details for Patent: 4,889,919

Title: Biologically active PDGF derived A-chain homodimers
Abstract:Dimeric proteins having substantially the same biological activity as PDGF are disclosed. More specifically, the protein may have two substantially identical polypeptide chains, each of the chains being substantially homologous to the A-chain of PDGF. Alternatively, the protein may have two polypeptide chains that are substantially identical to the A-chain of PDGF. In addition, proteins comprising polypeptides that are variants or derivatives of the A-chain of PDGF are also disclosed. Therapeutic compositions containing these proteins and methods for enhancing the wound-healing process in warm-blooded animals are also disclosed.
Inventor(s): Murray; Mark J. (Seattle, WA), Kelly; James D. (Seattle, WA)
Assignee: ZymoGenetics, Inc. (Seattle, WA)
Filing Date:Dec 15, 1986
Application Number:06/942,484
Claims:1. A substantially pure protein having two disulfide-bonded polypeptide chains, each of said chains comprising the amino acid sequence:

V X1 K T R T V I Y E I P R S Q V D P T S A N F L I W F P X2 V E V K R X3 T G X4 X5 X6 T S S V K C Q P S R V H H R S V K V A K V E Y V R K K P K L K E V Q V R L E E H L E C A C A T T S L N P D Y R E

wherein each of X1, X2, X3, X4, X5, and X6 is any amino acid.

2. A substantially pure protein having two disulfide-bonded polypeptide chains, each of said chains comprising the amino acid sequence:

Q V D P T S A N F L I W P P X2 V E V K R X3 T G X4 X5 X6 T S S V K C Q P S R V H H R S V K V A K V E Y V R K K P K L K E V Q V R L E E H L E C A C A T T S L N P D Y E wherein each of X2, X3, X4, X5, and X6 is any amino acid.

3. A substantially pure protein having two disulfide-bonded polypeptide chains, each of said chains comprising the amino acid sequence:

V X1 K T R T V I Y E I P R S Q V D P T S A N F L I W P P X2 V E V K R X3 T G X4 X5 X6 T S S V K C Q P S R V H H R S V K V A K V E Y V R K K P K L K E V Q V R L E E H L E C A C A T

wherein each of X1, X2, X3, X4, X5, and X6 is any amino acid.

4. A substantially pure protein having two disulfide-bonded polypeptide chains, each of said chains comprising the amino sequence:

Q V D P T S A N F L I W P P X2 V E V K R X3 T G X4 X5 X6 T S S V K C Q P S R V H H R S V K V A K V E Y V R K K P K L K E V Q V R L E E H L E C A C A T

wherein each of X2, X3, X4, X5 and X6 is any amino acid.

5. A substantially pure protein having two disulfide-bonded polypeptide chains, each of said chains comprising the amino acid sequence.

S I E E A V P A V X1 K T R T V I Y E I P R S Q V D P T S A N F L I W P P X2 V E V K R X3 T G X4 X5 X6 T S S V K C Q P S R V H H R S V K V A K V E Y V R K K P K L K E V Q V R L E E H L E C A C A T

wherein each of X1, X2, X3, X4, X5 and X6 is any amino acid.

6. A substantially pure protein having two disulfide-bonded polypeptide chains, each of said chains comprising the amino acid sequence:

S I E E A V P A V X1 K T R T V I Y E I P R S Q V D P T S A N F L I W P P X V E V K R X3 T G X4 X5 X6 T S S V K C Q P S V H H S V V A K V E Y V R K K P K L K E Q V R L E E H L E C A C A T T S L N P D Y R E

wherein each of X1, X2, X3, X4, X5 and X6 is any amino acid.

7. A protein according to any one of claims 1 to 48 wherein said protein is unglycosylated.

8. A protein according to any one of claims 1 to 48 wherein X6 is a glutamine residue.

9. A protein according to any one of claims 3, 5 and 6 wherein X1 is a serine residue.

10. A composition comprising a protein according to any of claims 1-9 and a physiologically acceptable carrier or diluent.

11. The composition of claim 10 wherein said carrier or diluent is selected from the group consisting of albumin, sterile water and saline.

12. The composition of claim 10, further comprising an adjuvant.

13. The composition of claim 12 wherein said adjuvant is selected from the group consisting of collagen, hyaluronic acid, fibronection, factor XIII, and an antibiotic.

14. The composition of claim 10 wherein said protein is present in a concentration of from about 10 ng/ml to about 100 ug/ml of total volume.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc